Trial of Pemetrexed and Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal Cancer
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine efficacy of the combination therapy of pemetrexed
and carboplatin as treatment for patients with platinum-sensitive ovarian cancer. This study
also includes patients with primary peritoneal cancer.